Novel fused oxazepino-indoles (FOIs) attenuate liver carcinogenesis via IL-6/JAK2/STAT3 signaling blockade as evidenced through data-based mathematical modeling
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 201, 161-172
Abstract
No abstract availableKeywords
Funding Information
- University Grants Commission (42-680/2013(SR))
- and Department of Science and Technology (DST) (DST/SB/EMEQ-320/2014)
This publication has 50 references indexed in Scilit:
- Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosisClinics and Research in Hepatology and Gastroenterology, 2013
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue MetabolomicsCancer Research, 2013
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cellsJournal of Inorganic Biochemistry, 2012
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancerInternational Journal of Cancer, 2010
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancerTrends in Molecular Medicine, 2008
- 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non‐involved breast tissueNMR in Biomedicine, 1994